Listar Neurocentre Magendie - U1215 por autor "PELLETIER, J."
Mostrando ítems 1-5 de 5
-
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality: The Excess Mortality vs the Cause-Specific Frameworks
ROLLOT, F.; UHRY, Z.; DANTONY, E. ...(Neurology. vol. 101, n° 24, pp. E2483-E2496, 2023-12-12)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
SHARMIN, S.; LEFORT, M.; ANDERSEN, J.B. ...(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
MATHAIS, S.; MOISSET, X.; PEREIRA, B. ...(Neurotherapeutics. vol. 18, n° 1, pp. 378-386, 2021-01)Article de revueLibre acceso -
Untreated patients with multiple sclerosis: a study of French expert centers
MOISSET, X.; FOUCHARD, A.-A.; PEREIRA, B. ...(European Journal of Neurology. vol. 28, n° 6, pp. 2026-2036, 2021-06)Article de revueLibre acceso -
Determinants of therapeutic lag in multiple sclerosis
ROOS, I.; LERAY, E.; FRASCOLI, F. ...(Multiple Sclerosis Journal. vol. 27, n° 12, pp. 1838-1851, 2021-10)Article de revueLibre acceso